Myasthenia Gravis Market Size, Share, And Growth Report 2032
Myasthenia Gravis Market By Diagnosis (Edrophonium Tests, Blood Tests, Pulmonary Function Tests, Electrodiagnostic, Imaging, And Others), By Treatment (Surgery, Medication, Plasmapheresis And Intravenous Immunoglobulin, Autologous Hematopoietic Stem Cell Transplantation (HSCT), And Others), And By End-User (Hospitals, Academic Research Institutes, Clinics, And Others), By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1460.84 Million | USD 2848.03 Million | 7.7% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Myasthenia Gravis Market, 2016-2025 (USD Million)
- 2.2. Global Myasthenia Gravis Market: Snapshot
- Chapter 3. Myasthenia Gravis Market - Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Myasthenia Gravis market drivers: Impact analysis
- 3.2.2. Increased prevalence of myasthenia gravis
- 3.2.3. Rising adoption of novel therapies
- 3.3. Market Restraints
- 3.3.1. Global Myasthenia Gravis market restraints: Impact analysis
- 3.3.2. High treatment costs
- 3.3.3. Limited availability of FDA-approved drugs
- 3.4. Opportunities
- 3.4.1. Research and development activities
- 3.4.2. Increasing investment
- 3.5. Porter's Five Forces analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Diagnosis
- 3.6.2. Market attractiveness analysis, by Treatment
- 3.6.3. Market attractiveness analysis, by End-User
- 3.6.4. Market attractiveness analysis, by Region
- Chapter 4. Global Myasthenia Gravis Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Myasthenia Gravis Market: company market share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. R&D
- 4.2.5. Regional Expansion
- 4.3. Price Trend Analysis
- 4.4. Technology Portfolio
- 4.1. Company Market Share Analysis
- Chapter 5. Global Myasthenia Gravis Market - Diagnosis Analysis
- 5.1. Global Myasthenia Gravis Market: Diagnosis overview
- 5.1.1. Global Myasthenia Gravis market revenue share, by Diagnosis, 2018 and 2025
- 5.2. Edrophonium Tests
- 5.2.1. Global Edrophonium Tests Market, 2016-2025 (USD Million)
- 5.3. Blood Tests
- 5.3.1. Global Blood Tests Market, 2016-2025 (USD Million)
- 5.4. Pulmonary Function Tests
- 5.4.1. Global Pulmonary Function Tests Market, 2016-2025 (USD Million)
- 5.5. Electrodiagnostic
- 5.5.1. Global Electrodiagnostic Market, 2016-2025 (USD Million)
- 5.6. Imaging
- 5.6.1. Global Imaging Market, 2016-2025 (USD Million)
- 5.7. Others
- 5.7.1. Global Others Market, 2016-2025 (USD Million)
- 5.1. Global Myasthenia Gravis Market: Diagnosis overview
- Chapter 6. Global Myasthenia Gravis Market - Treatment Analysis
- 6.1. Global Myasthenia Gravis: Treatment overview
- 6.1.1. Global Myasthenia Gravis Market revenue share, by Treatment, 2018 and 2025
- 6.2. Surgery
- 6.2.1. Global Surgery Market, 2016-2025 (USD Million)
- 6.3. Medication
- 6.3.1. Global Medication Market, 2016-2025 (USD Million)
- 6.4. Plasmapheresis and Intravenous Immunoglobulin
- 6.4.1. Global Plasmapheresis and Intravenous Immunoglobulin Market, 2016-2025 (USD Million)
- 6.5. Autologous Hematopoietic Stem Cell Transplantation (HSCT)
- 6.5.1. Global Autologous Hematopoietic Stem Cell Transplantation (HSCT) Market, 2016-2025 (USD Million)
- 6.6. Others
- 6.6.1. Global Others Market, 2016-2025 (USD Million)
- 6.1. Global Myasthenia Gravis: Treatment overview
- Chapter 7. Global Myasthenia Gravis Market - End-User Analysis
- 7.1. Global Myasthenia Gravis Market: End-User overview
- 7.1.1. Global Myasthenia Gravis Market revenue share, by End-User, 2018 and 2025
- 7.2. Hospitals
- 7.2.1. Global Hospitals Market, 2016-2025 (USD Million)
- 7.3. Academic Research Institutes
- 7.3.1. Global Academic Research Institutes Market, 2016-2025 (USD Million)
- 7.4. Clinics
- 7.4.1. Global Clinics Market, 2016-2025 (USD Million)
- 7.5. Others
- 7.5.1. Global Others Market, 2016-2025 (USD Million)
- 7.1. Global Myasthenia Gravis Market: End-User overview
- Chapter 8. Global Myasthenia Gravis Market - Regional Analysis
- 8.1. Global Myasthenia Gravis Market: Regional overview
- 8.1.1. Global Myasthenia Gravis Market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.2.2. North America Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.2.3. North America Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.2.4.2. The U.S. Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.2.4.3. The U.S. Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.2.5.2. Rest of North America Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.2.5.3. Rest of North America Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.3.2. Europe Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.3.3. Europe Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.3.4. Germany
- 8.3.4.1. Germany Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.3.4.2. Germany Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.3.4.3. Germany Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.3.5. France
- 8.3.5.1. France Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.3.5.2. France Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.3.5.3. France Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.3.6. UK
- 8.3.6.1. UK Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.3.6.2. UK Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.3.6.3. UK Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.3.7.2. Rest of Europe Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.3.7.3. Rest of Europe Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.4.2. Asia Pacific Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.4.3. Asia Pacific Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.4.4. China
- 8.4.4.1. China Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.4.4.2. China Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.4.4.3. China Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.4.5.2. Japan Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.4.5.3. Japan Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.4.6. India
- 8.4.6.1. India Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.4.6.2. India Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.4.6.3. India Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.4.7.2. Rest of Asia Pacific Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.4.7.3. Rest of Asia Pacific Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.5.2. Latin America Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.5.3. Latin America Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.5.4.2. Brazil Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.5.4.3. Brazil Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.5.5.2. Rest of Latin America Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.5.5.3. Rest of Latin America Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Myasthenia Gravis market revenue, by Diagnosis, 2016-2025 (USD Million)
- 8.6.2. The Middle East and Africa Myasthenia Gravis market revenue, by Treatment, 2016-2025 (USD Million)
- 8.6.3. The Middle East and Africa Myasthenia Gravis market revenue, by End-User, 2016-2025 (USD Million)
- 8.1. Global Myasthenia Gravis Market: Regional overview
- Chapter 9. Company Profile
- 9.1. Novartis Pharmaceuticals Corporation
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Diagnosis portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. AbbVie Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Diagnosis portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Biogen Inc.
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Diagnosis portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Pfizer
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Diagnosis portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Valeant Pharmaceuticals International
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Diagnosis portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Bristol-Myers Squibb Company
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Diagnosis portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. F. Hoffmann Roche La Ltd.
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Diagnosis portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. GlaxoSmithKline
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Diagnosis portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. RPG Life Sciences
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Diagnosis portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Grifols SA
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Diagnosis portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.1. Novartis Pharmaceuticals Corporation
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Myasthenia Gravis market revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Myasthenia Gravis market attractiveness analysis, by Diagnosis
6. Myasthenia Gravis Market: Market attractiveness analysis, by Treatment
7. Myasthenia Gravis market: Market attractiveness analysis, by End-User
8. Myasthenia Gravis Market: Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global Myasthenia Gravis market revenue share by Diagnosis, 2018 and 2025
11. Global Edrophonium Tests market, 2016–2025 (USD Million)
12. Global Blood Tests market, 2016–2025 (USD Million)
13. Global Pulmonary Function Tests market, 2016–2025 (USD Million)
14. Global Electrodiagnostic market, 2016–2025 (USD Million)
15. Global Imaging market, 2016–2025 (USD Million)
16. Global Others market, 2016–2025 (USD Million)
17. Global Myasthenia Gravis market revenue share by Treatment, 2018 and 2025
18. Global Surgery market, 2016–2025 (USD Million)
19. Global Medication market, 2016–2025 (USD Million)
20. Global Plasmapheresis and Intravenous Immunoglobulin market, 2016–2025 (USD Million)
21. Global Autologous Hematopoietic Stem Cell Transplantation (HSCT) market, 2016–2025 (USD Million)
22. Global Others market, 2016–2025 (USD Million)
23. Global Myasthenia Gravis market revenue share by End-User, 2018 and 2025
24. Global Hospitals market, 2016–2025 (USD Million)
25. Global Academic Research Institutes market, 2016–2025 (USD Million)
26. Global Clinics market, 2016–2025 (USD Million)
27. Global Others market, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Myasthenia Gravis: Market Snapshot
2. Drivers of global Myasthenia Gravis market: Impact analysis
3. Restraints of global Myasthenia Gravis market: Impact analysis
4. North America Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
5. North America Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
6. North America Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
7. The U.S. Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
8. The U.S. Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
9. The U.S. Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
10. Rest of North America Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
11. Rest of North America Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
12. Rest of North America Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
13. Europe Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
14. Europe Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
15. Europe Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
16. UK Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
17. UK Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
18. UK Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
19. Germany Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
20. Germany Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
21. Germany Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
22. France Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
23. France Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
24. France Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
25. Rest of Europe Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
26. Rest of Europe Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
27. Rest of Europe Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
28. Asia Pacific Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
29. Asia Pacific Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
30. Asia Pacific Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
31. China Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
32. China Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
33. China Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
34. Japan Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
35. Japan Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
36. Japan Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
37. India Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
38. India Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
39. India Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
40. Rest of Asia Pacific Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
41. Rest of Asia Pacific Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
42. Rest of Asia Pacific Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
43. Latin America Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
44. Latin America Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
45. Latin America Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
46. Brazil Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
47. Brazil Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
48. Brazil Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
49. Rest of Latin America Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
50. Rest of Latin America Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
51. Rest of Latin America Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
52. The Middle East and Africa Myasthenia Gravis market revenue, by Diagnosis, 2016–2025 (USD Million)
53. The Middle East and Africa Myasthenia Gravis revenue, by Treatment, 2016–2025 (USD Million)
54. The Middle East and Africa Myasthenia Gravis market revenue, by End-User type, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Myasthenia Gravis (MG) is a chronic autoimmune disorder characterized by weakness and rapid fatigue of voluntary muscles.
According to study, the Myasthenia Gravis market size was worth around USD 1460.84 million in 2023 and is predicted to grow to around USD 2848.03 million by 2032.
The CAGR value of Myasthenia Gravis market is expected to be around 7.7% during 2024-2032.
North America has been leading the Myasthenia Gravis market and is anticipated to continue on the dominant position in the years to come.
The Myasthenia Gravis market is led by players like Novartis Pharmaceuticals Corporation, AbbVie Inc., Biogen Inc., Pfizer, Valeant Pharmaceuticals International, Bristol-Myers Squibb Company, F. Hoffmann Roche La Ltd., GlaxoSmithKline, RPG Life Sciences, and Grifols SA, among others
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed